Cdh6 expression in ovarian cancer
WebFeb 24, 2024 · CDH6 is a cadherin family protein that is overexpressed in many tumor types, including kidney and ovarian carcinoma. This overexpression causes tumor … WebCDH6 could cause tumor cells to lose cellular polarity, further highlighting the potential for CDH6 as a target for antibody–drug conjugate (ADC) therapy develop-ment [22]. …
Cdh6 expression in ovarian cancer
Did you know?
WebMay 19, 2024 · Encouragingly, it was reported that HKT288, a CDH6-targeting ADC, could cause tumor regression in ovarian and renal cancer [23]. However, the clinical significance, as well as the diagnostic and ... WebJul 22, 2024 · Glioma is the most malignant cancer of the central nervous system. There are various therapies for treating gliomas, but their outcomes are not satisfactory. Therefore, new targets for glioma treatment are needed. This study examined the cadherin-6 (CDH6) expression in gliomas using The Cancer Genome Atlas and Chinese Glioma Genome …
WebPatients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows … WebJan 13, 2024 · Participants with ovarian cancer (OVC) or renal cell carcinoma (RCC) will receive an intravenous infusion of DS-6000a (starting dose 1.6 mg/kg). ... Has had prior treatment with other CDH6-targeted agents; Has had prior treatment with an ADC that consists of an exatecan derivative that is a topoisomerase I inhibitor (e.g., trastuzumab ...
WebMay 2, 2024 · In ovarian cancer, there was a significant overexpression of CDH6 as compared to ovarian tissues, but αIIbβ3 expression remained constant (Fig. S1C). In addition to the association between CDH6 and a worse prognosis in ovarian serous carcinoma, αIIbβ3 associated with poor prognosis in clear‐cell and papillary renal … WebMar 14, 2024 · Interaction of αIIbβ3 with CDH6, and subsequent αIIbβ3 activation, promoted activation of α2β1 and cell adhesion in ovarian and renal cancer cells. Additionally, monoclonal antibodies specific to the cadherin RGD motif and clinically approved αIIbβ3 inhibitors could block pro-metastatic activity in ovarian and renal tumors.
WebDec 8, 2024 · An in vivo study by Karthikeyan et al. confirmed that CDH6 was inhibited by mutant p53 in high-grade serous ovarian cancer, which suggests that CDH6 may be a biomarker for this condition 29. While ...
WebFeb 3, 2024 · Despite recent advances in targeted treatment, five-year survival rates for both renal cell carcinoma and ovarian cancer remain low and new therapeutic strategies are needed for tumors that continue to progress on currently available medicines. 1,2 CDH6 is a cadherin family protein overexpressed in several cancers, particularly renal cell and ... culinary school online programsWebCDH6 protein expression summary. This gene encodes a member of the cadherin superfamily. Cadherins are membrane glycoproteins that mediate homophilic cel l-cell … culinary school pensacola flWebThese results suggest that expression levels of certain proteins in ovarian cancers are estrogen-regulated and could help identify patients who would benefit from endocrine therapy. ... -positive ovarian cancer cell line, quantitative RT-PCR analysis demonstrated that PLAU, VIM, BIGH3, CDH6, FN1, CASP4, KRT4, KRT7, KRT13, TRAM and NGAL … culinary school online classes